blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2285801

EP2285801 - PROCESS FOR THE PREPARATION OF 5-(2-AMINO-PYRIMIDIN-4-YL)-2-ARYL-1H-PYRROLE-3-CARBOXAMIDES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.08.2014
Database last updated on 02.09.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
Nerviano Medical Sciences S.r.l.
11 Viale Pasteur, 10
20014 Nerviano (MI) / IT
[2011/08]
Inventor(s)01 / D'ANELLO, Matteo
Via Matteotti 18
I-20026 Novate Milanese / IT
02 / BATTISTINI, Carlo
Via G.Verga 1
I-20026 Novate Milanese / IT
03 / FORNARETTO, Maria Gioia
Via Carlo Marx 36
I-20153 Milan / IT
04 / VANOTTI, Ermes
Via Giovanni Cimabue 4
I-20148 Milan / IT
 [2011/08]
Application number, filing date09738214.730.04.2009
[2011/08]
WO2009EP55262
Priority number, dateEP2008015550130.04.2008         Original published format: EP 08155501
[2011/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009133170
Date:05.11.2009
Language:EN
[2009/45]
Type: A1 Application with search report 
No.:EP2285801
Date:23.02.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 05.11.2009 takes the place of the publication of the European patent application.
[2011/08]
Type: B1 Patent specification 
No.:EP2285801
Date:09.10.2013
Language:EN
[2013/41]
Search report(s)International search report - published on:EP05.11.2009
ClassificationIPC:C07D403/04
[2011/08]
CPC:
C07D403/04 (EP,US); A61P35/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/08]
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON 5-(2-AMINOPYRIMIDIN-4-YL)-2-ARYL-1H-PYRROL-3-CARBONSÄUREAMIDEN[2011/08]
English:PROCESS FOR THE PREPARATION OF 5-(2-AMINO-PYRIMIDIN-4-YL)-2-ARYL-1H-PYRROLE-3-CARBOXAMIDES[2011/08]
French:PROCÉDÉ DE PRÉPARATION DE 5-(2-AMINO- PYRIMIDIN-4-YL)-2-ARYL-1H-PYRROLE-3-CARBOXAMIDES[2013/07]
Former [2011/08]PROCÉDÉ DE PRÉPARATION DE 5-(2-AMINO- PYRIMIDIN-4-YL)-2-ARYL-LH-PYRROLE-3-CARBOXAMIDES
Entry into regional phase05.11.2010National basic fee paid 
05.11.2010Designation fee(s) paid 
05.11.2010Examination fee paid 
Examination procedure05.11.2010Amendment by applicant (claims and/or description)
05.11.2010Examination requested  [2011/08]
05.04.2012Despatch of a communication from the examining division (Time limit: M04)
10.07.2012Reply to a communication from the examining division
30.01.2013Communication of intention to grant the patent
27.05.2013Fee for grant paid
27.05.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  05.04.2012
Opposition(s)10.07.2014No opposition filed within time limit [2014/38]
Fees paidRenewal fee
25.04.2011Renewal fee patent year 03
27.08.2012Renewal fee patent year 04
27.08.2013Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.04.201204   M06   Fee paid on   27.08.2012
30.04.201305   M06   Fee paid on   27.08.2013
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU30.04.2009
BG09.10.2013
CY09.10.2013
CZ09.10.2013
DK09.10.2013
EE09.10.2013
FI09.10.2013
HR09.10.2013
LT09.10.2013
LV09.10.2013
MC09.10.2013
MK09.10.2013
MT09.10.2013
PL09.10.2013
RO09.10.2013
SI09.10.2013
SK09.10.2013
TR09.10.2013
NO09.01.2014
GR10.01.2014
IS09.02.2014
PT10.02.2014
LU30.04.2014
[2018/30]
Former [2016/33]HU30.04.2009
BG09.10.2013
CY09.10.2013
CZ09.10.2013
DK09.10.2013
EE09.10.2013
FI09.10.2013
HR09.10.2013
LT09.10.2013
LV09.10.2013
MC09.10.2013
MT09.10.2013
PL09.10.2013
RO09.10.2013
SI09.10.2013
SK09.10.2013
TR09.10.2013
NO09.01.2014
GR10.01.2014
IS09.02.2014
PT10.02.2014
LU30.04.2014
Former [2016/32]HU30.04.2009
BG09.10.2013
CY09.10.2013
CZ09.10.2013
DK09.10.2013
EE09.10.2013
FI09.10.2013
HR09.10.2013
LT09.10.2013
LV09.10.2013
MC09.10.2013
MT09.10.2013
PL09.10.2013
RO09.10.2013
SI09.10.2013
SK09.10.2013
NO09.01.2014
GR10.01.2014
IS09.02.2014
PT10.02.2014
LU30.04.2014
Former [2016/28]BG09.10.2013
CY09.10.2013
CZ09.10.2013
DK09.10.2013
EE09.10.2013
FI09.10.2013
HR09.10.2013
LT09.10.2013
LV09.10.2013
MC09.10.2013
MT09.10.2013
PL09.10.2013
RO09.10.2013
SI09.10.2013
SK09.10.2013
NO09.01.2014
GR10.01.2014
IS09.02.2014
PT10.02.2014
LU30.04.2014
Former [2016/16]CY09.10.2013
CZ09.10.2013
DK09.10.2013
EE09.10.2013
FI09.10.2013
HR09.10.2013
LT09.10.2013
LV09.10.2013
MC09.10.2013
MT09.10.2013
PL09.10.2013
RO09.10.2013
SI09.10.2013
SK09.10.2013
NO09.01.2014
IS09.02.2014
PT10.02.2014
LU30.04.2014
Former [2015/01]CY09.10.2013
CZ09.10.2013
DK09.10.2013
EE09.10.2013
FI09.10.2013
HR09.10.2013
LT09.10.2013
LV09.10.2013
MC09.10.2013
PL09.10.2013
RO09.10.2013
SI09.10.2013
SK09.10.2013
NO09.01.2014
IS09.02.2014
PT10.02.2014
LU30.04.2014
Former [2014/52]CY09.10.2013
CZ09.10.2013
DK09.10.2013
EE09.10.2013
FI09.10.2013
HR09.10.2013
LT09.10.2013
LV09.10.2013
MC09.10.2013
PL09.10.2013
RO09.10.2013
SI09.10.2013
SK09.10.2013
NO09.01.2014
IS09.02.2014
PT10.02.2014
Former [2014/41]CY09.10.2013
CZ09.10.2013
DK09.10.2013
EE09.10.2013
FI09.10.2013
HR09.10.2013
LT09.10.2013
LV09.10.2013
PL09.10.2013
RO09.10.2013
SI09.10.2013
SK09.10.2013
NO09.01.2014
IS09.02.2014
PT10.02.2014
Former [2014/37]CY09.10.2013
CZ09.10.2013
EE09.10.2013
FI09.10.2013
HR09.10.2013
LT09.10.2013
LV09.10.2013
PL09.10.2013
RO09.10.2013
SI09.10.2013
SK09.10.2013
NO09.01.2014
IS09.02.2014
PT10.02.2014
Former [2014/36]CY09.10.2013
EE09.10.2013
FI09.10.2013
HR09.10.2013
LT09.10.2013
LV09.10.2013
PL09.10.2013
SI09.10.2013
NO09.01.2014
IS09.02.2014
PT10.02.2014
Former [2014/28]CY09.10.2013
FI09.10.2013
HR09.10.2013
LT09.10.2013
LV09.10.2013
PL09.10.2013
SI09.10.2013
NO09.01.2014
IS09.02.2014
PT10.02.2014
Former [2014/26]CY09.10.2013
FI09.10.2013
HR09.10.2013
LT09.10.2013
LV09.10.2013
PL09.10.2013
SI09.10.2013
NO09.01.2014
IS09.02.2014
Former [2014/25]FI09.10.2013
HR09.10.2013
LT09.10.2013
LV09.10.2013
PL09.10.2013
SI09.10.2013
NO09.01.2014
IS09.02.2014
Former [2014/24]FI09.10.2013
HR09.10.2013
LT09.10.2013
PL09.10.2013
SI09.10.2013
NO09.01.2014
IS09.02.2014
Former [2014/23]FI09.10.2013
HR09.10.2013
LT09.10.2013
SI09.10.2013
NO09.01.2014
IS09.02.2014
Former [2014/22]FI09.10.2013
LT09.10.2013
SI09.10.2013
NO09.01.2014
Former [2014/20]LT09.10.2013
SI09.10.2013
NO09.01.2014
Former [2014/12]SI09.10.2013
Cited inInternational search[DA]WO2007110344  (NERVIANO MEDICAL SCIENCES SRL [IT], et al) [DA] 1-14* pages 16,29,47; figure 1; example 14; compounds F1-F36 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.